Unregistered Sales of Equity Securities and Use of Proceeds
−Removed: During the quarter ended March 31, 2024, we did not repurchase shares of our Common Stock.
+Added: The following tables provides information as of June 30, 2024, with respect to shares of Common Stock repurchased by the Company during the quarter then ended:
+Added: Fiscal Periods Total number of shares purchased
+Added: (thousands) Average price paid per share Total number of shares purchased as part of publicly announced plans or programs
+Added: (thousands) Approximate dollar value of shares that may yet be purchased under the plans or programs
+Added: 4/1/24-4/30/24
+Added: — $— — $1,700
+Added: 5/1/24-5/31/24
+Added: 298 $136.72 298 $1,659
+Added: 6/1/24-6/30/24
+Added: 68 $139.46 68 $—
+Added: Total 366 $137.24 366 $—
In September 2022, our Board of Directors authorized share repurchases of up to $ 2 billion (excluding applicable transaction fees) of our outstanding Common Stock through June 30, 2024.
−Removed: As of March 31, 2024, we have remaining capacity to repurchase up to $1.7 billion of Common Stock under this authorization.
+Added: Upon its expiration on June 30, 2024, we had remaining capacity to repurchase up to $ 1.65 billion of Common Stock under the September 2022 authorization.
+Added: In May 2024, our Board of Directors authorized share repurchases of up to $2 billion (excluding applicable transaction fees) of our outstanding Common Stock through December 31, 2026.
+Added: The new authorization took effect July 1, 2024 upon the expiration of the authorization approved in September 2022.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.